TTY BIOPHARM COMPANY LIMITED revenue for the last year amounted to 5.47 B TWD, the most of which — 2.43 B TWD — came from its highest performing source at the moment, Cancer Drugs, the year earlier bringing 2.97 B TWD. The greatest contribution to the revenue figure was made by Taiwan — last year it brought TTY BIOPHARM COMPANY LIMITED 4.84 B TWD, and the year before that — 4.60 B TWD.